Search results for "Genetic Variation"

showing 10 items of 836 documents

Towards a resolution of the lek paradox

2001

Genetic benefits in the shape of 'good genes' have been invoked to explain costly female choice in the absence of direct fitness benefits. Little genetic variance in fitness traits is expected, however, because directional selection tends to drive beneficial alleles to fixation. There seems to be little potential, therefore, for female choice to result in genetic benefits, giving rise to the 'lek paradox'. Nevertheless, evidence shows that genetic variance persists despite directional selection and genetic benefits of female choice are frequently reported. A theoretical solution to the lek paradox has been proposed on the basis of two assumptions: that traits are condition-dependent, and th…

MaleMultidisciplinarybiologyDirectional selectionEcologyCourtshipGenetic VariationOnthophagus taurusGenic capturebiology.organism_classificationBiological EvolutionModels BiologicalGenetic loadColeopteraSexual Behavior AnimalFixation (population genetics)Mate choiceFoodEvolutionary biologySexual selectionAnimalsFemaleGenetic variabilityNature
researchProduct

PLD3 gene variants and Alzheimer's disease

2015

MaleMultidisciplinarybusiness.industryGenetic VariationDiseaseComputational biologyBiologyText miningAlzheimer DiseasePhospholipase DHumansFemaleGenetic Predisposition to DiseasebusinessGeneNature
researchProduct

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior

2010

Contains fulltext : 89305.pdf (Publisher’s version ) (Closed access) Smoking is a common risk factor for many diseases. We conducted genome-wide association meta-analyses for the number of cigarettes smoked per day (CPD) in smokers (n = 31,266) and smoking initiation (n = 46,481) using samples from the ENGAGE Consortium. In a second stage, we tested selected SNPs with in silico replication in the Tobacco and Genetics (TAG) and Glaxo Smith Kline (Ox-GSK) consortia cohorts (n = 45,691 smokers) and assessed some of those in a third sample of European ancestry (n = 9,040). Variants in three genomic regions associated with CPD (P < 5 x 10(-8)), including previously identified SNPs at 15q25 repre…

MaleNetherlands Twin Register (NTR)Lung NeoplasmsSingle-nucleotide polymorphismGenome-wide association studyAetiology screening and detection [ONCOL 5]Receptors NicotinicGenetic analysisArticleMolecular epidemiology [NCEBP 1]Cohort Studies03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingOdds RatioGeneticsmedicine/dk/atira/pure/keywords/cohort_studies/netherlands_twin_register_ntr_HumansCYP2A6Lung cancerAlleles030304 developmental biologyGenetics0303 health sciencesbiologyCHRNA6CHRNA5Hormonal regulation [IGMD 6]SmokingGenetic VariationGenomicsTobacco Use DisorderOdds ratiomedicine.disease3. Good healthPhenotypeEvaluation of complex medical interventions [NCEBP 2]genome-wide association nicotinic acetylcholine-receptors lung-cancer susceptibility locus molecular-genetics heavy smoking adult twins dependence genes snpsbiology.protein/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemaleAryl Hydrocarbon Hydroxylases030217 neurology & neurosurgeryGenome-Wide Association Study
researchProduct

Susceptibility to infection with Borrelia afzelii and TLR2 polymorphism in a wild reservoir host

2019

AbstractThe study of polymorphic immune genes in host populations is critical for understanding genetic variation in susceptibility to pathogens. Controlled infection experiments are necessary to separate variation in the probability of exposure from genetic variation in susceptibility to infection, but such experiments are rare for wild vertebrate reservoir hosts and their zoonotic pathogens. The bank vole (Myodes glareolus) is an important reservoir host of Borrelia afzelii, a tick-borne spirochete that causes Lyme disease. Bank vole populations are polymorphic for Toll-like receptor 2 (TLR2), an innate immune receptor that recognizes bacterial lipoproteins. To test whether the TLR2 polym…

MaleNymph0301 basic medicinemetsämyyrälcsh:MedicineTickBorrelia afzeliimedicine.disease_causeinfektiotgenotyyppiArticle03 medical and health sciencesTicks0302 clinical medicineLyme diseaseBorrelia burgdorferi GroupPolymorphism (computer science)GenotypeGenetic variationparasitic diseasesisäntäeläimetImmunogeneticsmedicineAnimalsimmuniteettiGenetic Predisposition to Diseaselcsh:ScienceDisease ReservoirsGeneticsLyme DiseasePolymorphism GeneticMultidisciplinaryInnate immune systembiologyArvicolinaelcsh:REcological geneticsmedicine.diseasebiology.organism_classificationbacterial infections and mycosesToll-Like Receptor 2Borrelia-bakteeritBank vole030104 developmental biology[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyFemalelcsh:Q030217 neurology & neurosurgeryClethrionomys
researchProduct

Functional FLT1 genetic variation is a prognostic factor for recurrence in stage I-III non-small cell lung cancer

2015

Background: We propose that single-nucleotide polymorphisms (SNPs) in genes of the vascular endothelial growth factor pathway of angiogenesis will associate with survival in non-small-cell lung cancer (NSCLC) patients. Methods: Fifty-three SNPs in vascular endothelial growth factor-pathway genes were genotyped in 150 European stage I-III NSCLC patients and tested for associations with patient survival. Replication was performed in an independent cohort of 142 European stage I-III patients. Reporter gene assays were used to assess the effects of SNPs on transcriptional activity. Results: In the initial cohort, five SNPs associated (q < 0.05) with relapse-free survival (RFS). The minor allele…

MaleOncologyLung NeoplasmsAngiogenesisBioinformaticsmedicine.disease_causeCohort Studies0302 clinical medicineNon-small cell lung cancerVEGF pathwayCarcinoma Non-Small-Cell LungFLT1Aged 80 and over0303 health sciencesHazard ratioMiddle AgedPrognosis3. Good healthOncology030220 oncology & carcinogenesisFemaleKRASSNPsAdultPulmonary and Respiratory Medicinemedicine.medical_specialtySingle-nucleotide polymorphismPolymorphism Single NucleotideDisease-Free SurvivalArticle03 medical and health sciencesInternal medicineBiomarkers TumormedicineHumansNon–small cell lung cancerSNPLung cancerSurvival analysisAgedNeoplasm Staging030304 developmental biologyVascular Endothelial Growth Factor Receptor-1business.industryGenetic VariationMICROBIOLOGIAmedicine.diseaseSurvival AnalysisMinor allele frequencyNeoplasm Recurrence LocalbusinessEnhancer
researchProduct

Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study

2012

Background: In the MACRO study, patients with metastatic colorectal cancer (mCRC) were randomised to first-line treatment with 6 cycles of capecitabine and oxaliplatin (XELOX) plus bevacizumab followed by either single-agent bevacizumab or XELOX plus bevacizumab until disease progression. An additional retrospective analysis was performed to define the prognostic value of tumour KRAS status on progression-free survival (PFS), overall survival (OS) and response rates. Methodology/Principal Findings: KRAS data (tumour KRAS status and type of mutation) were collected by questionnaire from participating centres that performed KRAS analyses. These data were then cross-referenced with efficacy da…

MaleOncologyOrganoplatinum Compoundsendocrine system diseasesEpidemiologyColorectal cancer:Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings]DeoxycytidineMetastasis:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]Antineoplastic Combined Chemotherapy ProtocolsPathologyMedicineNeoplasm Metastasisgeneslcsh:Sciencemediana edad:Analytical Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols [Medical Subject Headings]Aged 80 and overanciano:Chemicals and Drugs::Organic Chemicals::Organometallic Compounds::Organoplatinum Compounds [Medical Subject Headings]Cancer Risk FactorsClinical Pharmacologyprotocolos de quimioterapia antineoplásica combinadaColon AdenocarcinomaPronósticoCombination chemotherapyadultoPrognosisBevacizumabOxaliplatinpronósticoOncologyMedicineOncology Agentsmedicine.medical_specialty:Phenomena and Processes::Genetic Phenomena::Genetic Variation::Mutation [Medical Subject Headings]FluorouraciloBevacizumab:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 1-Ring::Pyrimidines::Pyrimidine Nucleosides::Cytidine::Deoxycytidine [Medical Subject Headings]:Check Tags::Male [Medical Subject Headings]Molecular GeneticsCapecitabine:Chemicals and Drugs::Amino Acids Peptides and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies Monoclonal::Antibodies Monoclonal Humanized [Medical Subject Headings]Gastrointestinal TumorsGenetics:Named Groups::Persons::Age Groups::Adult [Medical Subject Headings]HumansClinical TrialsBiologyneoplasmsCapecitabineAgedlcsh:R:Diseases::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms [Medical Subject Headings]:Phenomena and Processes::Genetic Phenomena::Genetic Structures::Genome::Genome Components::Genes::Genes Neoplasm::Oncogenes::Proto-Oncogenes::Genes ras [Medical Subject Headings]medicine.diseasedigestive system diseasesOxaliplatin:Check Tags::Female [Medical Subject Headings]PharmacogeneticsMutationlcsh:QfluorouraciloMultivariate analysisDesoxicitidinahumanosCancer Treatment:Named Groups::Persons::Age Groups::Adult::Aged::Aged 80 and over [Medical Subject Headings]lcsh:Medicinemedicine.disease_causeNeoplasias colorrectalesSurgical oncologyBasic Cancer Research:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 1-Ring::Pyrimidines::Pyrimidinones::Uracil::Fluorouracil [Medical Subject Headings]Clinical Trials (Cancer Treatment)metástasis neoplásicaMetástasis neoplásicaMultidisciplinaryMiddle AgedGenetic EpidemiologyProtocolos de quimioterapia antineoplásica combinadaFemaleAntiangiogenesis TherapyFluorouracilKRASColorectal NeoplasmsResearch Articlemedicine.drugAdultDrugs and DevicesClinical Pathologyneoplasias colorrectalesClinical Research DesignGenetic Causes of CancerAntibodies Monoclonal HumanizedAntibodiesRectal CancerAntibody TherapyDiagnostic MedicineInternal medicine:Diseases::Neoplasms::Neoplastic Processes::Neoplasm Metastasis [Medical Subject Headings]:Named Groups::Persons::Age Groups::Adult::Aged [Medical Subject Headings]mutaciónClinical GeneticsMutaciónbusiness.industryPharmacoepidemiologyCancers and NeoplasmsHuman GeneticsChemotherapy and Drug TreatmentdesoxicitidinaGenes rasanticuerposGenetics of Diseasebusinesscompuestos organoplatinoPLoS ONE
researchProduct

Exploring the potential of life-history key innovation: brook breeding in the radiation of the Malagasy treefrog genus Boophis

2002

The treefrog genus Boophis is one of the most species-rich endemic amphibian groups of Madagascar. It consists of species specialized to breeding in brooks (48 species) and ponds (10 species). We reconstructed the phylogeny of Boophis using 16S ribosomal DNA sequences (558 bp) from 27 species. Brook-breeders were monophyletic and probably derived from an ancestral pond-breeding lineage. Pond-breeders were paraphyletic. The disparity in diversification among pond-breeders and brook-breeders was notable among endemic Malagasy frogs, although it was not significant when considering Boophis alone. Sibling species which have different advertisement calls but are virtually indistinguishable by mo…

MaleParaphylyLineage (evolution)MantellidaeMolecular Sequence DataMantellidaeZoologyFresh WaterBreedingphylogenyAmphibiaMonophylysibling speciesGenusddc:570RNA Ribosomal 16SMadagascarGeneticsAnimalsPhylogenyEcology Evolution Behavior and SystematicsKey innovationLikelihood FunctionsbiologyReproductionGenetic Variationbiology.organism_classificationGenetic divergenceBoophisFemaleAnuraMolecular Ecology
researchProduct

Genetic and Environmental Influences on the Relationship Between Aggression and Hyperactivity-impulsivity as Rated by Teachers and Parents

2004

This study examined genetic and environmental contributions to the covariance between aggression and hyperactivity-impulsivity as rated by twins' teachers and parents. Sex-differences in these genetic and environmental contributions and rater bias/sibling interaction effects were of interest as well. Part of an ongoing nation-wide twin-family study of behavioral development and health habits, the sample consisted of 1636 Finnish twin pairs ascertained from five consecutive and complete twin birth cohorts. Data were collected at ages 11-12, using teacher and parental rating forms of the Multidimensional Peer Nomination Inventory. Bivariate analyses were performed using structural equation mo…

MaleParents050103 clinical psychologyGenotypeTwinsChild BehaviorBivariate analysisStructural equation modelingDevelopmental psychologyCorrelationSex FactorsSurveys and QuestionnairesGenetic variationTwins DizygoticmedicineHumans0501 psychology and cognitive sciencesLongitudinal StudiesSiblingHyperactivity impulsivityFinlandGenetics (clinical)Aggression4. Education05 social sciencesGenetic VariationObstetrics and GynecologyTwins MonozygoticFacultyPhenotypeChild PreschoolPediatrics Perinatology and Child HealthFemalemedicine.symptomPsychologySocial psychologyHealth habits050104 developmental & child psychologyTwin Research
researchProduct

Genetic and Environmental Influences on BMI From Late Childhood to Adolescence are Modified by Parental Education

2011

To investigate how parental education modifies genetic and environmental influences on variation in BMI during adolescence, self-reported BMI at 11-12, 14, and 17 years of age was collected from a population sample of 2,432 complete Finnish twin pairs born in 1983-1987. Based on parental report, twins were divided to those with high (both parents high school graduates), mixed level (one parent a graduate, the other not), and limited (neither parent a graduate) parental education. Genetic and environmental influences on variation in BMI in different education classes were modeled using twin analysis. Heritability of BMI among 11-12-year-olds with high parental education was 85-87% whereas it…

MaleParentsPediatricsmedicine.medical_specialtyAdolescentEndocrinology Diabetes and MetabolismTwinsMedicine (miscellaneous)Social EnvironmentAffect (psychology)Body Mass Index03 medical and health sciences0302 clinical medicineEndocrinologyParental educationGenetic variationmedicineHumansObesityProspective Studies030212 general & internal medicineChildSocioeconomic statusFinlandta515030304 developmental biology0303 health sciencesNutrition and DieteticsParentingGenetic VariationSocial environmentHeritabilityTwin studyEducational StatusFemaleSelf ReportPsychologyBody mass indexDemographyObesity
researchProduct

Chronic active hepatitis associated with vitiligo, nail dystrophy, alopecia and a new variant of LKM antibodies

1990

In this report we describe the case of a 7-year-old boy, suffering from autoimmune-type chronic active hepatitis (AI-CAH) associated with vitiligo, nail dystrophy, alopecia areata and a variant of liver kidney microsomal (LKM) autoantibodies. This patient's antibodies are different from LKM-1 which are directed against cytochrome P450 db1. They react predominantly with perivenous hepatocytes in contrast to LKM-1 antibodies which homogeneously stain the whole liver lobule in immunofluorescence. In Western blot analysis this LKM variant reacts with a liver microsomal protein of approx. 50 kDa, but not with recombinant LKM-1 (cytochrome P450 db1) antigen. Immunosuppressive treatment led to a n…

MalePathologymedicine.medical_specialtyBlotting WesternVitiligoFluorescent Antibody TechniqueVitiligoImmunofluorescenceAutoimmune DiseasesNail DiseasesAntigenmedicineHumansChildskin and connective tissue diseasesAutoantibodiesHepatitis ChronicAutoimmune diseaseHepatitisintegumentary systemHepatologybiologymedicine.diagnostic_testbusiness.industryAutoantibodyGenetic VariationAlopeciaAlopecia areatamedicine.diseaseImmunologybiology.proteinAntibodybusinessJournal of Hepatology
researchProduct